A detailed history of Capital Investment Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Capital Investment Advisors, LLC holds 2,221 shares of BIIB stock, worth $330,973. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,221
Previous 2,197 1.09%
Holding current value
$330,973
Previous $509,000 15.52%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$189.07 - $236.8 $4,537 - $5,683
24 Added 1.09%
2,221 $430,000
Q2 2024

Jul 12, 2024

BUY
$190.52 - $236.72 $61,156 - $75,987
321 Added 17.11%
2,197 $509,000
Q1 2024

Apr 15, 2024

SELL
$212.02 - $267.71 $26,714 - $33,731
-126 Reduced 6.29%
1,876 $404,000
Q4 2023

Jan 05, 2024

SELL
$222.59 - $267.94 $667 - $803
-3 Reduced 0.15%
2,002 $518,000
Q3 2023

Oct 16, 2023

BUY
$253.3 - $285.89 $3,039 - $3,430
12 Added 0.6%
2,005 $515,000
Q2 2023

Jul 11, 2023

SELL
$275.25 - $318.06 $275 - $318
-1 Reduced 0.05%
1,993 $567,000
Q1 2023

Apr 10, 2023

BUY
$256.56 - $292.34 $1,795 - $2,046
7 Added 0.35%
1,994 $554,000
Q4 2022

Jan 05, 2023

BUY
$252.44 - $306.72 $34,836 - $42,327
138 Added 7.46%
1,987 $550,000
Q3 2022

Oct 05, 2022

SELL
$194.69 - $268.46 $30,176 - $41,611
-155 Reduced 7.73%
1,849 $494,000
Q2 2022

Jul 06, 2022

SELL
$187.54 - $223.02 $21,942 - $26,093
-117 Reduced 5.52%
2,004 $409,000
Q1 2022

Apr 13, 2022

SELL
$193.77 - $244.14 $70,726 - $89,111
-365 Reduced 14.68%
2,121 $447,000
Q4 2021

Jan 10, 2022

SELL
$223.92 - $287.77 $29,109 - $37,410
-130 Reduced 4.97%
2,486 $596,000
Q3 2021

Oct 13, 2021

SELL
$282.99 - $369.05 $136,967 - $178,620
-484 Reduced 15.61%
2,616 $740,000
Q2 2021

Jul 14, 2021

SELL
$259.0 - $414.71 $80,549 - $128,974
-311 Reduced 9.12%
3,100 $1.07 Million
Q1 2021

Apr 27, 2021

SELL
$242.95 - $284.63 $39,600 - $46,394
-163 Reduced 4.56%
3,411 $954,000
Q4 2020

Jan 21, 2021

SELL
$236.26 - $355.63 $120,020 - $180,660
-508 Reduced 12.44%
3,574 $875,000
Q3 2020

Oct 29, 2020

SELL
$264.77 - $305.71 $31,772 - $36,685
-120 Reduced 2.86%
4,082 $1.16 Million
Q2 2020

Jul 20, 2020

BUY
$258.66 - $342.55 $61,819 - $81,869
239 Added 6.03%
4,202 $1.12 Million
Q1 2020

Apr 13, 2020

SELL
$268.85 - $341.04 $238,201 - $302,161
-886 Reduced 18.27%
3,963 $1.25 Million
Q4 2019

Jan 21, 2020

SELL
$220.06 - $304.07 $112,890 - $155,987
-513 Reduced 9.57%
4,849 $1.44 Million
Q3 2019

Oct 24, 2019

BUY
$217.44 - $243.88 $180,475 - $202,420
830 Added 18.31%
5,362 $1.25 Million
Q2 2019

Jul 17, 2019

BUY
$219.29 - $241.72 $777,821 - $857,380
3,547 Added 360.1%
4,532 $1.06 Million
Q1 2019

Apr 11, 2019

SELL
$216.71 - $338.96 $11,052 - $17,286
-51 Reduced 4.92%
985 $233,000
Q4 2018

Jan 17, 2019

BUY
$278.5 - $352.75 $1,114 - $1,411
4 Added 0.39%
1,036 $312,000
Q3 2018

Oct 15, 2018

SELL
$293.51 - $383.83 $35,221 - $46,059
-120 Reduced 10.42%
1,032 $365,000
Q2 2018

Jul 10, 2018

BUY
$257.52 - $306.91 $36,052 - $42,967
140 Added 13.83%
1,152 $334,000
Q1 2018

Apr 16, 2018

BUY
$260.13 - $367.91 $263,251 - $372,324
1,012 New
1,012 $277,000
Q4 2017

Jan 17, 2018

SELL
$307.64 - $344.58 $377,781 - $423,144
-1,228 Closed
0 $0
Q3 2017

Oct 17, 2017

BUY
$281.15 - $329.69 $345,252 - $404,859
1,228
1,228 $385,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Capital Investment Advisors, LLC Portfolio

Follow Capital Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisors, LLC with notifications on news.